NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Chou R, Dana T, Blazina I, et al. Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Nov. (Evidence Syntheses, No. 139.)

Cover of Statin Use for the Prevention of Cardiovascular Disease in Adults

Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Show details

Table 1Statin Dosing and ACC/AHA Classification of Intensity

StatinDosage
Low-intensity
(LDL-C reduction <30%)
Moderate-intensity
(LDL-C reduction 30% to <50%)
High-intensity
(LDL-C reduction >50%)
AtorvastatinNA10 to 20 mg40 to 80 mg
Fluvastatin20 to 40 mg40 mg 2×/day; XL 80 mgNA
Lovastatin20 mg40 mgNA
Pitavastatin1 mg2 to 4 mgNA
Pravastatin10 to 20 mg40 to 80 mgNA
RosuvastatinNA5 to 10 mg20 to 40 mg
Simvastatin10 mg20 to 40 mgNA

From ACC/AHA, 2013.30 Dosages shown are total daily dosages; exceptions are noted.

Abbreviations: ACC=American College of Cardiology; AHA=American Heart Association; LDL-C=low-density lipoprotein cholesterol; NA=not applicable.

Views

  • Cite this Page
  • PDF version of this title (1.5M)